Cargando…

Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice

Due to the paucity of targetable antigens, triple-negative breast cancer (TNBC) remains a challenging subtype of breast cancer to treat. In this study, we developed and evaluated a chimeric antigen receptor (CAR) T cell-based treatment modality for TNBC by targeting stage-specific embryonic antigen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfeifer, Rita, Al Rawashdeh, Wa’el, Brauner, Janina, Martinez-Osuna, Manuel, Lock, Dominik, Herbel, Christoph, Eckardt, Dominik, Assenmacher, Mario, Bosio, Andreas, Hardt, Olaf T., Johnston, Ian C. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252441/ https://www.ncbi.nlm.nih.gov/pubmed/37298141 http://dx.doi.org/10.3390/ijms24119184

Ejemplares similares

Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma
por: Schäfer, Daniel, et al.
Publicado: (2021)

A Novel Siglec-4 Derived Spacer Improves the Functionality of CAR T Cells Against Membrane-Proximal Epitopes
por: Schäfer, Daniel, et al.
Publicado: (2020)

Enhancing the Efficacy of CAR T Cells in the Tumor Microenvironment of Pancreatic Cancer
por: Henze, Janina, et al.
Publicado: (2020)

The sialyl-glycolipid SSEA4 marks a subpopulation of chemotherapy resistant breast cancer cells with mesenchymal features
por: Aloia, Andrea, et al.
Publicado: (2015)

Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma
por: Teppert, Karin, et al.
Publicado: (2023)

Development of Fluorescently Labeled SSEA-3, SSEA-4, and Globo-H Glycosphingolipids for Elucidating Molecular Interactions in the Cell Membrane
por: Asano, Sachi, et al.
Publicado: (2019)

A multimodal imaging workflow for monitoring CAR T cell therapy against solid tumor from whole-body to single-cell level
por: Pfeifer, Rita, et al.
Publicado: (2022)

MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors
por: Kinkhabwala, Ali, et al.
Publicado: (2022)

Titratable Pharmacological Regulation of CAR T Cells Using Zinc Finger-Based Transcription Factors
por: Kotter, Bettina, et al.
Publicado: (2021)

mTORC1 Maintains the Tumorigenicity of SSEA-4(+) High-Grade Osteosarcoma
por: Zhang, Wu, et al.
Publicado: (2015)

Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells
por: Cordes, Nicole, et al.
Publicado: (2021)

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer
por: Blomqvist, Matias, et al.
Publicado: (2021)

Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces
por: Venable, Alison, et al.
Publicado: (2005)

SSEA‐4 and YKL‐40 positive progenitor subtypes in the subventricular zone of developing human neocortex
por: Brøchner, Christian B., et al.
Publicado: (2015)

Author Correction: mTORC1 Maintains the Tumorigenicity of SSEA-4 (+) High-Grade Osteosarcoma
por: Zhang, Wu, et al.
Publicado: (2021)

Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells
por: Werchau, Niels, et al.
Publicado: (2022)

Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosis
por: Yu, Cheng-Chia, et al.
Publicado: (2016)

SSEA-4 positive dental pulp stem cells from deciduous teeth and their induction to neural precursor cells
por: Lopez-Lozano, Ada Pricila, et al.
Publicado: (2022)

Joining Forces for Cancer Treatment: From “TCR versus CAR” to “TCR and CAR”
por: Teppert, Karin, et al.
Publicado: (2022)

FAS-Based Cell Depletion Facilitates the Selective Isolation of Mouse Induced Pluripotent Stem Cells
por: Warlich, Eva, et al.
Publicado: (2014)

Automated, scaled, transposon-based production of CAR T cells
por: Lock, Dominik, et al.
Publicado: (2022)

Small SSEA-4-positive cells from human ovarian cell cultures: related to embryonic stem cells and germinal lineage?
por: Virant-Klun, Irma, et al.
Publicado: (2013)

Bone Marrow SSEA1+ Cells Support the Myocardium in Cardiac Pressure Overload
por: Finan, Amanda, et al.
Publicado: (2013)

Ex vivo expanded SSEA-4+ human limbal stromal cells are multipotent and do not express other embryonic stem cell markers
por: Lim, Moon Nian, et al.
Publicado: (2012)

TGF-β Signaling Accelerates Senescence of Human Bone-Derived CD271 and SSEA-4 Double-Positive Mesenchymal Stromal Cells
por: Kawamura, Hiroshi, et al.
Publicado: (2018)

Circulating SSEA-1(+) stem cell-mediated tissue repair in allergic airway inflammation
por: Chiu, Chiao-Juno, et al.
Publicado: (2022)

Isolation of Small SSEA-4-Positive Putative Stem Cells from the Ovarian Surface Epithelium of Adult Human Ovaries by Two Different Methods
por: Virant-Klun, Irma, et al.
Publicado: (2013)

Organoid-derived C-Kit(+)/SSEA4(−) human retinal progenitor cells promote a protective retinal microenvironment during transplantation in rodents
por: Zou, Ting, et al.
Publicado: (2019)

Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors
por: Jamali, Arezoo, et al.
Publicado: (2019)

Photoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers
por: Beztsinna, Nataliia, et al.
Publicado: (2017)

Continuous Hypoxic Culturing of Human Embryonic Stem Cells Enhances SSEA-3 and MYC Levels
por: Närvä, Elisa, et al.
Publicado: (2013)

Quantitative Analysis of SSEA3+ Cells from Human Umbilical Cord after Magnetic Sorting
por: Leng, Zikuan, et al.
Publicado: (2019)

Upregulation of mitochondrial NAD(+) levels impairs the clonogenicity of SSEA1(+) glioblastoma tumor-initiating cells
por: Son, Myung Jin, et al.
Publicado: (2017)

Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
por: Pinz, Kevin G., et al.
Publicado: (2017)

CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities–Merits and Challenges
por: Harrer, Dennis C., et al.
Publicado: (2019)

Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells
por: Fang, Karen Kai-Lin, et al.
Publicado: (2023)

Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting
por: Seitz, Christian M., et al.
Publicado: (2021)

Human intracardiac SSEA4+CD34 cells show features of cycling, immature cardiomyocytes and are distinct from Side Population and C-kit+CD45- cells
por: Sandstedt, Mikael, et al.
Publicado: (2022)

Target selection for CAR-T therapy
por: Wei, Jianshu, et al.
Publicado: (2019)

Decitabine-Mediated Upregulation of CSPG4 in Ovarian Carcinoma Cells Enables Targeting by CSPG4-Specific CAR-T Cells
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rum06g1g7ne64nt3heu5bb8fje